Recent Quarter Total Invested
$140.35 M
Recent Quarter Institutional Ownership Percentage
88.31%
Total Invested of Last Quarter
$225.68 M
Ownership Percentage of Last Quarter
92.88%
Elevation Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 3.85 M | $10.40 M | 285.00% | 6.52% |
FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 3.60 M | $9.72 M | -7.42% | 6.10% |
TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 3.06 M | $8.26 M | 0.00% | 5.18% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 2.96 M | $7.99 M | 100.00% | 5.01% |
AISLING CAPITAL MANAGEMENT LP | 08/08/2024 | 2.83 M | $7.65 M | 0.00% | 4.80% |
BLACKROCK INC. | 08/13/2024 | 2.49 M | $6.72 M | 1,348.65% | 4.22% |
BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 2.48 M | $6.71 M | -18.72% | 4.21% |
BRAIDWELL LP | 08/14/2024 | 2.48 M | $6.69 M | 4.20% | 4.20% |
VENBIO PARTNERS LLC | 08/14/2024 | 2.43 M | $6.57 M | -9.71% | 4.12% |
HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2024 | 2.40 M | $6.47 M | 58.70% | 4.06% |
BVF INC/IL | 08/14/2024 | 2.31 M | $6.24 M | 0.00% | 3.92% |
VANGUARD GROUP INC | 08/13/2024 | 1.92 M | $5.18 M | 25.13% | 3.25% |
DARWIN GLOBAL MANAGEMENT, LTD. | 08/14/2024 | 1.92 M | $4.81 M | -17.86% | 3.25% |
PALO ALTO INVESTORS LP | 08/14/2024 | 1.80 M | $4.86 M | 33.67% | 3.05% |
POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 1.68 M | $4.54 M | -50.11% | 2.85% |
AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 1.47 M | $3.97 M | 15.76% | 2.49% |
MORGAN STANLEY | 10/17/2024 | 1.27 M | $3.44 M | 4,436.77% | 2.16% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.03 M | $2.79 M | 196.06% | 1.75% |
ARTAL GROUP S.A. | 08/14/2024 | 1.01 M | $2.74 M | -33.05% | 1.72% |
ORBIMED ADVISORS LLC | 08/14/2024 | 941,275 | $2.54 M | 0.00% | 1.59% |
STATE STREET CORP | 08/14/2024 | 897,033 | $2.42 M | 711.06% | 1.52% |
OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 747,000 | $2.02 M | 100.00% | 1.27% |
IKARIAN CAPITAL, LLC | 08/14/2024 | 690,089 | $1.86 M | 366.00% | 1.17% |
WALLEYE CAPITAL LLC | 08/14/2024 | 615,837 | $1.66 M | -21.71% | 1.04% |
GHOST TREE CAPITAL, LLC | 08/14/2024 | 600,000 | $1.62 M | 140.00% | 1.02% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2024 | 597,299 | $1.61 M | 20.11% | 1.01% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 504,131 | $1.36 M | -8.52% | 0.85% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 386,400 | $1.04 M | 119.01% | 0.65% |
EXOME ASSET MANAGEMENT LLC | 10/03/2024 | 369,322 | $997,169 | 0.00% | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 08/14/2024 | 330,000 | $891,000 | -23.26% | 0.56% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 183,728 | $496,066 | -25.11% | 0.31% |
BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 183,493 | $495,431 | 366.00% | 0.31% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 153,586 | $414,683 | 100.00% | 0.26% |
AMERIPRISE FINANCIAL INC | 08/14/2024 | 141,329 | $381,589 | 596.10% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 134,546 | $363,274 | 100.00% | 0.23% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 131,898 | $356,124 | -7.59% | 0.22% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 128,000 | $345,600 | 20.19% | 0.22% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 116,068 | $313,384 | 100.00% | 0.20% |
NORTHERN TRUST CORP | 08/14/2024 | 97,059 | $262,059 | 49.79% | 0.16% |
PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2024 | 91,994 | $248,384 | -8.28% | 0.16% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 84,927 | $229,303 | 884.20% | 0.14% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 81,187 | $219,205 | 100.00% | 0.14% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 72,985 | $197,060 | 6.78% | 0.12% |
RHUMBLINE ADVISERS | 08/01/2024 | 64,910 | $175,251 | 100.00% | 0.11% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 59,456 | $160,531 | 100.00% | 0.10% |
JANE STREET GROUP, LLC | 08/15/2024 | 50,120 | $135,324 | -36.48% | 0.08% |
ALPINE GLOBAL MANAGEMENT, LLC | 08/14/2024 | 50,103 | $135,278 | 100.00% | 0.08% |
JUMP FINANCIAL, LLC | 08/14/2024 | 49,455 | $133,528 | 100.00% | 0.08% |
AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 49,222 | $132,899 | 55.67% | 0.08% |
CITADEL ADVISORS LLC | 08/14/2024 | 40,113 | $108,305 | -97.44% | 0.07% |
Elevation Oncology, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ELEV shares?
During the previous two years, 86 institutional investors and hedge funds held shares of Elevation Oncology, Inc.. The most heavily invested institutionals were:
Ameritas Advisory Services, LLC: 0
Logos Global Management LP: 3.85 M
FARALLON CAPITAL MANAGEMENT LLC: 3.6 M
TANG CAPITAL MANAGEMENT LLC: 3.06 M
Frazier Life Sciences Management, L.P.: 2.96 M
Aisling Capital Management LP: 2.83 M
-
What percentage of Elevation Oncology, Inc. stock is owned by institutional investors?
88.31% of Elevation Oncology, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ELEV ?
Institutional investors have bought a total of 52.05 M shares in the last 24 months. This purchase volume represents approximately $27.07 M in transactions.